Input-and layer-dependent synaptic plasticity in the rat perirhinal cortex in vitro.
The perirhinal cortex is crucially important in several forms of memory. Whilst it is important to understand the underlying mechanisms of this role in memory, little is known about the synaptic physiology or plasticity of this region of transitional cortex. In this study, we recorded evoked field potentials in superficial layers (approximately layer I) of the perirhinal cortex in vitro. One stimulating electrode was placed on the temporal side and the other on the entorhinal side of the rhinal sulcus in either the superficial or intermediate layers (approximately layers II/III). Paired stimuli resulted in depression of the second response. Paired-pulse depression was maximal at a 200-ms interpulse interval. Low-frequency stimulation resulted in synaptic depression, which returned to baseline within 60 min. The magnitude of both paired-pulse depression and low-frequency stimulation-induced depression was significantly greater at synapses activated from the temporal intermediate pathway than the other three pathways. Long-term potentiation, stable for at least 60 min, was induced by high-frequency stimulation of intermediate but not superficial pathways. Long-lasting depression (depotentiation) was induced by low-frequency stimulation following the induction of long-term potentiation. The induction of both long-term potentiation and depotentiation was N-methyl-D-aspartate receptor dependent. The group I/II metabotropic glutamate receptor antagonist (S)-alpha-methyl-4-carboxyphenylglycine was without effect on either of these forms of plasticity. Thus, both long- and short-lasting forms of synaptic plasticity exist at synapses in the perirhinal cortex, and these may mediate the changes in neuronal responses associated with visual recognition memory.
MRC Centre for Synaptic Plasticity, Department of Anatomy, School of Medical Sciences, University of Bristol, UK.
Z
Z
Ziakopoulos
C W
CW
Tillett
M W
MW
Brown
Z I
ZI
Bashir
D015763:2-Amino-5-phosphonovalerate / Q000494:pharmacology; D000818:Animals; D001565:Benzoates / Q000494:pharmacology; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D005998:Glycine / Q000031:analogs & derivatives / Q000494:pharmacology; D017774:Long-Term Potentiation / Q000187:drug effects / Q000502:physiology*; D008297:Male; D019579:Neocortex / Q000187:drug effects / Q000502:physiology*; D009473:Neuronal Plasticity / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology*
D001565:Benzoates; D018691:Excitatory Amino Acid Antagonists; C079694:alpha-methyl-4-carboxyphenylglycine; D015763:2-Amino-5-phosphonovalerate; D005998:Glycine